test

Wuwei Tang

@E Fund Management Co., Ltd.

Latest period2024 - Q3ReportedManaged Assets$1.946BTotal holdings353
Assets growth rate7.6%Assets growth rate (2-Q avg)9.81%Continuous growth in asset value5 quarters

Portfolio positions

This chart displays the top 10 holdings in E Fund Management Co., Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 353 positions.

Assets under management

The assets under management (AUM) of E Fund Management Co., Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.946B in assets, with a quarterly growth rate of 7.6% and a 2-quarter average growth rate of 9.81%. The portfolio is managed by Wuwei Tang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APHAmphenol Corp
Recent Activity
Decreased -39.84%
0.06%
$1.134M
17,405 shares@ $65.16 avg price
EXASExact Sciences Corp
Recent Activity
Decreased -38.33%
0.06%
$1.129M
16,576 shares@ $68.12 avg price
NTRANatera Inc
Recent Activity
Decreased -13.94%
0.06%
$1.09M
8,587 shares@ $126.95 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Decreased -0.51%
0.06%
$1.089M
8,716 shares@ $124.89 avg price
VKTXViking Therapeutics Inc
Recent Activity
Decreased -20.11%
0.06%
$1.031M
16,280 shares@ $63.31 avg price
BMRNBiomarin Pharmaceutical Inc
Recent Activity
Decreased -5.07%
0.05%
$899,430
12,796 shares@ $70.29 avg price
NKENike Inc
Recent Activity
Decreased -40.14%
0.04%
$745,212
8,430 shares@ $88.4 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -13.75%
0.04%
$725,313
13,737 shares@ $52.8 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -4.34%
0.03%
$489,054
10,784 shares@ $45.35 avg price
ROIVRoivant Sciences Ltd
Recent Activity
Decreased -16.41%
0.03%
$485,972
42,112 shares@ $11.54 avg price